Subtype
Liver Carcinoma
CI-CAN-00001073Explore in graph →
783 active trials14 approved drugs17 evidence items
- NCIt
- C7927
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001073Explore in graph →
Clinical trials
3,367 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (386)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07543510 | Low-Dose Bevacizumab and Atezolizumab Combined With TACE-HAIC in Unresectable Hepatocellular Carcinoma | not yet recruiting | N/A | 38 | Third Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 0 | Apr 22, 2026 | clinicaltrials |
| NCT07544121 | Effect of Babao Dan Capsule Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis | not yet recruiting | N/A | 1,034 | Nanfang Hospital, Southern Medical UniversityOTHER | 0 |
| Apr 22, 2026 |
| clinicaltrials |
| NCT07537959 | Surgery Plus Systemic Therapy for Liver Cancer With Extrahepatic Metastases | not yet recruiting | N/A | 280 | Tongji HospitalOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT07476651 | Scout Dose of Resin Microspheres(LASER) | recruiting | N/A | 30 | Seoul National University HospitalOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT04785534 | Surveys, Blood Testing, and Fibroscan in Screening for Liver Fibrosis and Liver Cirrhosis | active not recruiting | N/A | 1,000 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT06426992 | Clinical Effectiveness of Microwave Ablation Using Starwave Microwave Generator for Hepatic Malignancies | recruiting | N/A | 128 | Seoul National University HospitalOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT04180072 | Atezolizumab Plus Bevacizumab With HCC and HBV Infection | active not recruiting | N/A | 51 | National Health Research Institutes, TaiwanOTHER | 1 | Apr 9, 2026 | clinicaltrials |
| NCT06910722 | Liver Transplantation for Locally Advanced Intrahepatic Cholangiocarcinoma After SIRT and Chemotherapy(RIS-TH) | recruiting | N/A | 36 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Apr 6, 2026 | clinicaltrials |
| NCT07493070 | Ultra-stable Iodized Oil-Chemo Embolization Seq Thermal Ablation in Early Liver Ca | active not recruiting | N/A | 30 | Fujian Medical University Union HospitalOTHER | 1 | Mar 25, 2026 | clinicaltrials |
| NCT05629845 | Prevention of Variceal Rebleeding by EUS-guided vs Conventional Endoscopic Therapy in Hepatocellular Carcinoma Patients(EUS-SPV) | recruiting | N/A | 84 | Chinese University of Hong KongOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT06077591 | Prospective Clinical Validation of Next Generation Sequencing (NGS) and Patient-Derived Tumor Organoids (PDO) Guided Therapy in Patients With Advanced/ Inoperable Solid Tumors(PDO) | recruiting | N/A | 40 | Chinese University of Hong KongOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT07481032 | Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study | not yet recruiting | N/A | 1,034 | Nanfang Hospital, Southern Medical UniversityOTHER | 0 | Mar 18, 2026 | clinicaltrials |
| NCT05095714 | FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer.(FASTRAK) | recruiting | N/A | 944 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Mar 12, 2026 | clinicaltrials |
| NCT06537193 | Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment | recruiting | N/A | 455 | Asan Medical CenterOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT05953337 | Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC) | active not recruiting | N/A | 120 | ABK BiomedicalINDUSTRY | 2 | Mar 4, 2026 | clinicaltrials |
| NCT07428356 | Histotripsy for Ablation of Liver Tumours in Asia(HALT) | recruiting | N/A | 40 | National Cancer Centre, SingaporeOTHER | 1 | Feb 23, 2026 | clinicaltrials |
| NCT07408804 | Comparison of Response Between Combination of Transarterial Chemoembolization and Lenvatinib Therapy Versus Lenvatinib Monotherapy in Patients With Unresectable Hepatocellular Carcinoma | recruiting | N/A | 40 | Bangladesh Medical UniversityOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT07395635 | Phase II Trial of Immunonutrition in Hepatectomy | recruiting | N/A | 100 | Tata Memorial CentreOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT05375370 | Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Monitoring Circulating Tumor DNA(REMNANT) | recruiting | N/A | 150 | University Hospital, RouenOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT06061328 | Project OASIS: Optimizing Approaches to Select Implementation Strategies(OASIS) | enrolling by invitation | N/A | 8,020 | VA Office of Research and DevelopmentFED | 1 | Feb 4, 2026 | clinicaltrials |
| NCT04736121 | Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres® Y-90 Resin Microspheres on DoR & ORR in Unresectable Hepatocellular Carcinoma Patients(DOORwaY90) | active not recruiting | N/A | 100 | Sirtex MedicalINDUSTRY | 1 | Feb 3, 2026 | clinicaltrials |
| NCT07178587 | Evaluating the roLe of Multiplexed PET Imaging in the Detection and Staging of hepatocellulaR Carcinoma and gAstro-entero-pancreatic Tumors(ELMIRA) | recruiting | N/A | 28 | Nantes University HospitalOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT01918683 | TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients | active not recruiting | N/A | 40 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT07368049 | MR 7700 Multinuclear Application Clinical Study | not yet recruiting | N/A | 100 | Philips Clinical & Medical Affairs GlobalINDUSTRY | 0 | Jan 26, 2026 | clinicaltrials |
| NCT07039201 | A Study to Evaluate CG-102-12C in Glypican-3 (GPC3) Positive Advanced Hepatocellular Carcinoma (HCC) | recruiting | N/A | 12 | Zhejiang UniversityOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT06689670 | Needle-based Percutaneous Ablation of Liver Tumors. | recruiting | N/A | 31 | inTumo Therapeutics, Inc.INDUSTRY | 1 | Jan 20, 2026 | clinicaltrials |
| NCT07337031 | A Trial of Behavioral Intervention on Prognostic Survival of Patients With Unresectable Liver Cancer | not yet recruiting | N/A | 193 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Jan 13, 2026 | clinicaltrials |
| NCT04573881 | The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy (#HOPE4LIVER EU/UK)(#HOPE4LIVER) | active not recruiting | N/A | 24 | HistoSonics, Inc.INDUSTRY | 4 | Jan 12, 2026 | clinicaltrials |
| NCT07306481 | The Efficacy of Preoperative Oral Administration of Lactobacillus Reuteri Combined With Preoperative Neoadjuvant/Conversion Immunotherapy in Patients With Primary Resectable Liver Cancer | not yet recruiting | N/A | 40 | Fujian Cancer HospitalOTHER_GOV | 0 | Dec 29, 2025 | clinicaltrials |
| NCT04684862 | Infusion System for Hepatic Cancer | active not recruiting | N/A | 100 | Ronald DeMatteo, M.D.OTHER | 1 | Dec 15, 2025 | clinicaltrials |
| NCT07281664 | Transarterial Chemoembolization With Low-Dose Bevacizumab Plus Atezolizumab as First-Line Treatment for Unresectable Hepatocellular Carcinoma | not yet recruiting | N/A | 30 | Third Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 0 | Dec 15, 2025 | clinicaltrials |
| NCT07253220 | TAF Monotherapy Versus ETV Combined With TAF on the Efficacy and Prognosis of Immunotherapy for Hepatitis B-Related Hepatocellular Carcinoma | not yet recruiting | N/A | 120 | Sun Yat-sen UniversityOTHER | 0 | Nov 28, 2025 | clinicaltrials |
| NCT07243691 | Study on the Therapeutic Effect of Different Infusion Times of Tislelizumab on Postoperative High-risk Hepatocellular Carcinoma | recruiting | N/A | 33 | Sir Run Run Shaw HospitalOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT04572633 | The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy(#HOPE4LIVER US) | active not recruiting | N/A | 47 | HistoSonics, Inc.INDUSTRY | 1 | Nov 19, 2025 | clinicaltrials |
| NCT01796145 | Fibroscan Study in HCC | active not recruiting | N/A | 207 | Chinese University of Hong KongOTHER | 1 | Nov 17, 2025 | clinicaltrials |
| NCT07192731 | International Study on Treatment of Liver (HCC) Patients With IRE(LIVERHCC-IRE) | not yet recruiting | N/A | 50 | Angiodynamics, Inc.INDUSTRY | 1 | Oct 10, 2025 | clinicaltrials |
| NCT07208526 | A Randomized Trial of Surgical Decision-Making Guided by TDTP-RECIST | not yet recruiting | N/A | 270 | Shanghai Zhongshan HospitalOTHER | 1 | Oct 6, 2025 | clinicaltrials |
| NCT05971108 | Real-world Elecsys® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC(REVISE-HCC) | recruiting | N/A | 600 | Manchester University NHS Foundation TrustOTHER_GOV | 1 | Sep 24, 2025 | clinicaltrials |
| NCT07178093 | Effects of Antrodia Cinnamomea on the Hepatoma Patients After Transcatheter Hepatic Artery Chemoembolization | recruiting | N/A | 60 | Taichung Tzu Chi HospitalOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT06541990 | Psychoeducational Intervention for Patients With Hepatocellular Carcinoma(HARMONY) | recruiting | N/A | 50 | Massachusetts General HospitalOTHER | 1 | Aug 29, 2025 | clinicaltrials |
| NCT06740370 | TACE Combined With Lenvatinib and PD-1 Inhibitor for Ruptured Hepatocellular Carcinoma | recruiting | N/A | 32 | Sun Yat-sen UniversityOTHER | 1 | Aug 14, 2025 | clinicaltrials |
| NCT05433467 | CT-guided Localization for Micro Hepatocellular Carcinoma Before Surgical Resection(CTMH) | recruiting | N/A | 5 | Northern Jiangsu People's HospitalOTHER | 1 | Aug 13, 2025 | clinicaltrials |
| NCT07118735 | AHCC® as Immune Modulator in Cancer Patients Treated With Immunotherapy(NCKUH) | not yet recruiting | N/A | 94 | National Cheng-Kung University HospitalOTHER | 1 | Aug 12, 2025 | clinicaltrials |
| NCT07115550 | A Single-center, Single-arm, Phase II Clinical Study of Iparomlimab and Tuvonralimab Injection Combined With Regorafenib in the Treatment of Advanced Second-line or Above Hepatocellular Carcinoma | not yet recruiting | N/A | 24 | Huai'an First People's HospitalOTHER | 0 | Aug 11, 2025 | clinicaltrials |
| NCT05953961 | 90Y Transarterial Radioembolization Versus Microwave Ablation in Small Hepatocellular Carcinoma With Hypoalbuminemia(REALM) | recruiting | N/A | 50 | Ochsner Health SystemOTHER | 1 | Aug 3, 2025 | clinicaltrials |
| NCT07088133 | Clinical Trials of the Hepatitis B Sandwich Combination Therapy for Treating Patients Infected With Hepatitis B Virus | not yet recruiting | N/A | 12 | Shanghai Zhongshan HospitalOTHER | 0 | Jul 28, 2025 | clinicaltrials |
Data updated 22 days agoSource updated Apr 22, 2026source: clinicaltrials